Our aim was to determine if less expensive interictal indices can predict which epilepsy patients may benefit from the more expensive comprehensive pre-surgical evaluation. Surgical treatment was determined based on the results of a comprehensive inpatient continuous video-EEG monitoring. This evaluation included three interictal tests, which were reviewed retrospectively-2 hour-sleep-deprived electroencephalogram (SDEEG), magnetic resonance imaging (MRI), and positron emission tomography (PET). Sixty-nine patients were evaluated with 35 patients having focal resection (33 temporal, two frontal). When two or more interictal tests were positive, 77% (27/35) went to surgery, but when one test was positive 23% (8/34) had surgery. When all tests were negative, only a single patient (1/13 or 7.7%) had surgery, a frontal resection. The positive predictive value for any single interictal test was 68%, while it was higher for any combination of two positive tests (77-83%). PET was the most sensitive (0.86) single interictal test, compared to SDEEG (0.66) and MRI (0.66). The odds ratio for predicting surgical treatment for a positive PET, SDEEG, or MRI was 8.57, 4.01, and 4.01, respectively. MRI was three and PET was six times the cost of a SDEEG. The combination of SDEEG and MRI had the best cost/PPV ratio. Seventy-nine percent (11/14) of the patients with three positive tests were seizure free following focal resection compared to 43% (9/21) when less than three tests were positive (P ≤ 0.05). Interictal tests may predict which patients are most likely to benefit from comprehensive pre-surgical evaluation. Two or more positive tests are the most predictive. If all tests are negative, it is unlikely that the patient would qualify for surgical treatment. The combination of SDEEG and MRI may be more cost-effective as outpatient screening tools.
INTRODUCTION
Although of substantial diagnostic benefit in the selection of patients with medically intractable epilepsy for focal resection, pre-surgical evaluation that includes analysis of 24 hour-video-EEG telemetry (ictal and interictal EEG), multi-modality imaging, neuropsychological evaluation and WADA testing is very expensive. Several investigators have addressed the need for a cost/benefit analysis of the comprehensive evaluation [1] [2] [3] . To date, there have been two evaluations of the cost-effectiveness of anterior temporal lobectomy in the US 4, 5 . These were based on complex models with many variables but appeared to demonstrate marginally favorable results when compared to other operative procedures. However, all patients who underwent pre-surgical evaluation were included in the costs incurred for ATL. While it is difficult to determine the percent of non-surgical candidates in one series, 33% of the patients were deemed unsuitable candidates after the inpatient evaluation for ATL 4 . This represents a substantial increase in the overall cost of ATL. Improving the selection process for patients who are to be considered for inpatient pre-surgical evaluation may aid in reducing the overall cost of ATL and thereby increase the cost/benefit ratio.
To determine if a patient might benefit from the presurgical evaluation, epilepsy centers typically assess patient history, seizure semiology, physical exam, and the routine EEG. However, even with this assessment, many patients undergo an expensive comprehensive pre-surgical evaluation who are ultimately ineligible for surgical resection. We sought to determine if less expensive interictal tests could reliably predict the outcome of the comprehensive pre-surgical evaluation, i.e. surgical treatment or surgical ineligibility. To address this question, we chose to evaluate three interictal tests that are routinely utilized during our inpatient evaluation, the 2 hour-SDEEG, MRI, and PET and compare them to cost. These tests can be done on an outpatient basis to assess surgical eligibility.
PATIENTS AND METHODS
Ninety-nine consecutive patients were admitted for pre-surgical evaluation between October 1993 and April 1996 at Baptist Hospital, Wake Forest University. Pre-surgical evaluation included 24 hourvideo-EEG monitoring with electrographic analysis of interictal data (2 hour-SDEEG tracing obtained during sleep), ictal data, seizure semiology, ictal SPECT, PET, MRI, and neuropsychological assessment. The interictal tests (SDEEG, MRI and PET) were determined to be positive or negative at the time of the pre-surgical evaluation and used in the determination of surgical candidacy. These test results were retrospectively compiled.
Thirty patients were excluded from the study that had large structural lesions (tumors, infarcts, cysts, encephalomalacia) (17) , prior intracranial surgery (two), progressive neurological disease (one), or did not have all three interictal tests (10) . Sixty-nine patients were evaluated. Based on the results of the comprehensive evaluation, patients were recommended for focal resective surgery (23), further evaluation with invasive electrode recordings (14) , or non-surgical medical treatment (32). Following the evaluation with invasive recordings, patients were recommended for focal surgery (12) or determined to be ineligible for surgical resection (two). Of the 69 patients included in the study, 37 were female while 32 were male. Ages ranged from 11 to 66 years, mean 35 years. Seizure onset ranged from Birth to 38 years, with a mean onset of 10 years and mean duration 25 years.
EEG. There is no definitive method of data collection between institutions in the determination of lateralization/localization of the interictal EEG during the pre-surgical evaluation. Various methods for evaluation of interictal spikes include evaluation of the baseline EEG at the onset of the inpatient monitoring prior to medication taper, continuous assessment of time samples during the entire monitoring period, sleep-deprived recordings, and combinations of early baseline and time samples obtained throughout the monitoring period [6] [7] [8] [9] [10] . Additionally, one series utilized six outpatient EEGs, comprising three pairs of awake and asleep recordings in their determination 11 . As part of our pre-surgical protocol we routinely assess a 2 hour-SDEEG based on previously published criteria 9 . Spikes and sharp waves were manually counted during each inpatient evaluation. This was determined pre-operatively relatively early in the evaluation and thus was not biased by surgical candidacy. SDEEGs were considered positive if there was ≥90% lateralization of epileptiform discharges. The interictal spikes were additionally classified by location (temporal, frontal, fronto-temporal, parietal, occipital). To be considered positive there had to be six or more epileptiform discharges or less than six but with concordant focal background slowing. SDEEGs were considered negative if there was <90% lateralization of epileptiform discharges, less than six discharges without slowing, and multifocal or generalized SDEEGs. Ictal data was not used in the determination of the positivity or negativity of the SDEEG. Post-ictal spikes were not counted until the background had returned to normal for each patient. The SDEEG was performed on average during the fourth day of admission without significant difference between the surgical and non-surgical groups, 3.71 and 3.68, respectively. On the average, each patient had 2.2 seizures prior to the SDEEG being recorded with the proportion slightly higher in the non-surgical group compared to the surgical group, 2.8 and 1.7, respectively. The mean number of seizures that occurred during the SDEEG was 0.5, however, this result was skewed by one patient who had 27 brief 4-12 seconds non-localizing electrographic seizures during the tracing. This patient was also in the nonsurgical group and had a negative SDEEG with no localized spikes and sharp waves. Excluding this patient the mean was 0.1 seizures/tracing. Additionally, one of these patients had intractable frontal lobe epilepsy, with typically two to 10 seizures per day prior to the recording. There was no significant difference in the number of seizures during the SDEEG for the surgical group compared to the non-surgical group, 11% (4/35) and 15% (5/34), respectively (P = 0.72).
MRI. High-resolution MRI images of the temporal lobes were obtained using a fast spin echo T2-weighted sequence (TR 4000/TE eff 102) and a T1-weighted 3D-FT, spoiled gradient echo sequence (TR 45/TE 5 and a 35 degree flip angle). In addition to subjective interpretation for lesions or abnormalities, 47/64 (75.8%) had hippocampal volumes calculated following thresholding and segmentation of the hippocampus bilaterally by computer analysis of 3 mm contiguous coronal T2-weighted images. There was no significant difference in the percent of patients with volumetric analysis in the surgical group compared to the non-surgical group, 77% (27/35) and 71% (24/34), respectively (P = 0.81). Additionally, a blind reading was performed on 28 of the images in which volumetric data was obtained. MRIs with discrete lesions, or with focal unilateral hippocampal atrophy or abnormal signal changes were considered positive. Patients with large lesions were excluded.
PET. An interictal PET using 10 mCi[ 18 F] FDG was obtained on the first or second day of admission prior to medication taper and ictal recordings. An EEG was performed during the uptake phase of the FDG to ensure that the study was obtained during the interictal period. The PET was considered positive if there was a focal area of glucose hypometabolism.
The interictal tests were analyzed within categories; three interictal tests, two interictal tests, and single interictal tests. Within the category of two interictal tests, the SDEEG and MRI, the MRI and PET, and the SDEEG and PET were separately assessed. Additionally, the data was analyzed separately according to the number of positive tests within each category. None of the patients with three positive tests had discordant results. Only four patients with two positive tests had discordant results. For data analysis, this pair of discordant tests would be considered under the category of one positive test as ultimately only one side would be surgically remedial.
A 2 × 2 analysis was performed for each test and combinations of tests. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and the odds ratio were calculated. The odds ratio was calculated by: [P(A)/P(not A)]/[P(B)/P(not B)] with the numerator denoting odds of undergoing surgery and the denominator representing the odds of not having surgery. Statistical significance was set at ≤0.05. The accuracy of a test was determined by calculating the percent of patients with true test positive results and true test negative results/total number of patients.
The direct cost for each test was determined by contact with the appropriate billing personnel for each department and included hospital and physician charges. Indirect costs were not included. Cost was also calculated for each combination of tests. The cost for each test and test combinations was compared to the least expensive test, the 2 hour-sleep-deprived EEG, and a relative cost for each was determined. A cost/benefit ratio was determined in which benefit was equated to the positive or negative predictive value.
RESULTS
Of the 69 patients evaluated, 35 had a focal resection (33 temporal, two frontal). Of the 33 temporal lobectomies, 17 were right and 16 were left. Thirtyfour patients did not fulfill the criteria for surgical eligibility. Two patients who had three positive tests were ineligible for surgery due to the demonstration of a contralateral temporal ictal onset compared to the three interictal tests and bilateral independent posterior quadrant ictal onsets, respectively, with surface recorded EEG. Additionally, two patients who had two positive tests were ineligible for surgery due to bilateral independent temporal ictal onsets with one confirmed by invasive electrode recordings. Follow-up ranged from 1 year and 10 months to 4 years (mean = 3 years). 57.1% (20/35) of the patients were seizure-free following focal resection (Engel Class I), while 80% (28/35) were seizure-free or had improved control (Engel class I/II) 12 .
Prediction of surgical and non-surgical treatment
In the category of three interictal tests, when all three tests were positive, 82.4% (14/17) of the patients underwent focal resection, compared to 40.4% (21/52) when less then three tests were positive (P ≤ 0.01). When any two or all three tests were positive, 77.1% (27/35) had surgery, but when zero or one test was positive, 23.5% (8/34) had surgery (P ≤ 0.001). However, when all three tests were negative, only 7.7% (1/13) had surgery (frontal resection) (P ≤ 0.001). When all three tests were positive, 17.6% (3/17) were ineligible for surgery, while when two or three tests were positive 22.9% (8/35) were ineligible.
In the category of two interictal tests, each combination of two positive tests were predictive of focal surgical resection: PET and MRI, SDEEG and MRI, SDEEG and PET, 83.3% (20/24), 78.9% (15/19), 76.9% (20/26), respectively (P ≤ 0.01). Although the combination of a positive PET and MRI predicted a slightly higher rate of focal surgical resection compared to the other combinations, it was not statistically significant. Considering combinations Table 1 demonstrates the sensitivity, specificity, PPV, NPV and odds ratio within each category of interictal tests. The best positive predictor across the categories of three interictal tests or two interictal tests was when all tests within that category were positive. Within these categories, there was greater sensitivity when one or more tests were positive as compared to requiring all tests to be positive. However when fewer tests were positive, the specificity was reduced.
Predictive utility of interictal tests
For the category of three interictal tests, when all three were positive, the tests were very specific but not sensitive in detecting all surgical cases. The best combination of sensitivity and specificity occurred within the group of any two or more positive tests. The odds for predicting if a patient would undergo surgery when one or more tests were positive was 18.6 times greater than when all the tests were negative.
When comparing two interictal tests, the combination of a positive SDEEG and MRI was specific, but not very sensitive. Combining the PET with either the SDEEG or MRI increased the sensitivity compared to the combination of SDEEG and MRI. The combination of PET and SDEEG had the best odds ratio for any two positive tests.
Among single interictal tests, the PET was the most sensitive, but slightly less specific than the SDEEG or MRI. Additionally, the PET had the highest odds ratio for predicting surgical treatment (8.57). It was also the most accurate test having the highest proportion of true positive and true negative tests (72.5%), compared to MRI (66.7%) and SDEEG (66.7%).
Cost
The category of three interictal tests was the most expensive method and had the highest cost/PPV [ Fig. 1 ]. In the category of two interictal tests, the combination of SDEEG and MRI was the least expensive, and had the best cost/PPV ratio. Among single interictal tests, the SDEEG was the least expensive and had the best cost/PPV ratio.
Post-surgical seizure freedom and interictal tests
When comparing all three interictal tests in predicting seizure freedom following focal resection, only when all three interictal tests were positive was there a statistically significant proportion of patients seizure-free compared to when less than three tests were positive, 78.6% (11/14) and 42.9% (9/21), respectively (P ≤ 0.05). Although each of the following combinations of three interictal tests were not significant, proportionately less patients were seizure-free when successively fewer interictal tests were positive. When three tests were positive, 92.9% (13/14) had improved control (Engel I/II), compared to 71.4% (15/21) when less than three tests were positive. When only two of three interictal tests were positive, 50% (7/14) were seizure-free, while 28.6% (2/7) were seizure free when less than two of three tests were positive. When two of three tests were positive 78.6% (11/14) had improved seizure control (Engel I/II) compared to 57.1% (4/7) when less than two of three tests were positive. When only one of three tests were positive, 33% (2/6) were seizurefree, and 66.7% (4/6) were improved (Engel I/II) compared to no improvement when all three interictal tests were negative (1/1).
Regarding combinations of two interictal tests in predicting seizure freedom, only the combination of both a positive MRI and a positive PET was statistically significant with 71.4% (15/21) of the patients becoming seizure free compared to 35.7% (5/14) seizure free when less than both tests were positive (P ≤ 0.05). The combination of a positive SDEEG and MRI, or a positive SDEEG and PET trended towards significance in predicting seizure freedom (P ≤ 0.1). When only one interictal test of a particular combination of two tests was positive, the predicted seizure-free rate declined by 11% on the average.
There was no significant difference between positive single interictal tests in predicting seizure freedom for the SDEEG 65.2% (15/23), MRI 65.2% (15/23), or PET 63.3% (19/30) compared to when each of these tests were negative, SDEEG 41.7% (5/12), MRI 41.7% (5/12), or PET 20% (1/5), respectively.
DISCUSSION
We examined three interictal tests, the 2 hour-sleepdeprived EEG, MRI, and PET based on the outcome of focal surgical resection vs. surgical ineligibility of patients admitted for pre-surgical evaluation. Although these three interictal tests form part of the expensive comprehensive inpatient evaluation, our results show that these less expensive interictal tests can predict eligibility for surgical treatment, and, perhaps more importantly, surgical ineligibility. Many series have demonstrated the predictive capabilities of interictal tests in temporal lobe epilepsy [6] [7] [8] [9] [10] [11] [13] [14] [15] [16] [17] .
However, none have reported the best combination of three interictal tests in predicting surgical eligibility, especially in relation to cost.
In our series, any single positive test could predict surgical eligibility in approximately 68% (PPV) of the patients. The PET was the best negative predictor of surgical eligibility (NPV 80%). It also had the best odds ratio for predicting surgery (8.6). However, it was also the single most expensive test. Comparatively, the SDEEG was the least expensive single test and thus had the best cost/benefit ratio.
When comparing two interictal tests, the most information was obtained when both tests were positive or both were negative. Additionally, any combination of two positive tests (range 77%-83%) was more predictive of surgery than any single test (68%). The least expensive combination, and slightly better predictor for surgical treatment, was the SDEEG and MRI. Regarding each of the two test combinations, it was also slightly more predictive of post-operative seizure freedom (73%), but was not significant. When attempting to minimize cost, this combination would appear to be the most effective. Many clinicians obtain an outpatient MRI before considering a patient for pre-surgical evaluation. To maintain cost-effectiveness, the relatively inexpensive SDEEG could be added to the clinician's arsenal of outpatient tools to increase the predictive value.
The most specific combination and very strong predictor of surgical treatment was when all tests were positive in the category of three interictal tests. However, it was also the most expensive combination, 9.3 times the cost of the SDEEG alone. However, when all three interictal tests were positive, this was a strong predictor of seizure freedom (79%) compared to any combination of fewer than three positive tests (42.9%). Additionally, there was a graded decline in those achieving seizure freedom with each drop in the number of positive tests from three positive, two positive, one positive, zero positive to 79, 50, 33, and 0%, respectively. Only one subject (3%), that we would have predicted to be ineligible for focal resection having negative results in all three tests, had a frontal lobe resection (NPV 92%), but this was a palliative procedure. None of the patients undergoing temporal lobe resection had negative results in all three interictal tests. Hence, the performance of all three tests, which may be used in the outpatient setting, may allow exclusion of patients who are not appropriate surgical candidates, thus saving the cost of an expensive comprehensive inpatient evaluation. Under these conditions, the patient would also have a higher likelihood of a good surgical outcome following focal resection (86%). This would also give a more accurate characterization of the likelihood of a good surgical outcome prior to surgery.
Due to increasing economic constraints in health care, it could be argued that when two or three of the interictal tests are positive and concordant, the inpatient comprehensive evaluation could be eliminated. We would argue against such an approach. When we analyzed all three interictal tests, 22.9% (8/35) of the patients that we would have predicted to be good surgical candidates based on two or three positive interictal tests were ineligible for focal resection. Conversely, 23.5% (8/34) of the patients that we would have predicted to be ineligible, zero or one positive tests, were ultimately determined to have surgically treatable epilepsy upon completion of the comprehensive evaluation. Nevertheless, two or three positive and concordant interictal tests were highly predictive of surgical treatment. Consequently, the performance of these tests in the outpatient setting could yield valuable diagnostic information. If two or more tests were positive and concordant, the patient would have a high probability for surgical eligibility following completion of the comprehensive inpatient evaluation.
There are several limitations when trying to extrapolate our data to the outpatient setting. The MRI and PET can easily be performed in the outpatient setting. However, the sleep-deprived EEG may be more problematic. There is an inherent problem of trying to keep an outpatient awake for 24 hours. During the inpatient monitoring this is accomplished by the constant vigilance of the technical staff, but in the outpatient setting, patients tend not to stay awake all night and may be only partially sleep deprived (personal observation). This raises the question of whether partial sleep deprivation is equivalent to a fully sleep-deprived recording. In one surgical series, six outpatient non-sleep-deprived EEGs totaling 4.5 hours of recording was predictive of seizure freedom at 5-year follow up 11 . Thus is the distinction between partial sleep deprivation and full sleep deprivation that important? Further studies may be necessary to evaluate this. Another question concerns how a few seizures in the days immediately prior to the SDEEG impact the data. There was no significant difference in our series between the surgical and non-surgical group in the number of seizures prior to recording the SDEEG. Additionally, since the SDEEG was done typically on day 4 of admission, a slow anticonvulsant taper was underway. However, does this taper have any impact on the diagnostic yield of the SDEEG? Later in the monitoring period when anticonvulsants have been withdrawn and the patient has had several seizures, spike frequency may increase in secondary foci, but the site of maximum abnormality can remain relatively stable 6 . However, this effect would tend to lower the spike ratio below 90%, making it a negative test in our series. This would thus lower the predictive value and increase the cost/PPV ratio. Therefore, our tests could potentially have a higher predictive value if performed on outpatients on their maintenance anticonvulsants.
As a first approximation of cost-effectiveness, recent studies have demonstrated marginal cost-effectiveness of ATL with the results highly dependent on surgical outcome and quality of life 4, 5 . Since many patients need to undergo the comprehensive evaluation in order to determine the best surgical candidates, the use of these three interictal tests in the outpatient setting, may help reduce the overall lifetime costs incurred per patient by improving the selection of appropriate surgical candidates. In one surgical series patients with 100% localized spikes on six outpatient awake and asleep EEG recordings underwent ATL without inpatient evaluation providing that there were no other discordant results 11 . In their group of 28 non-monitored patients 61% were seizure free while 93% had a ≥75% reduction in seizure frequency at 5-year follow up. These proportions were similar to their inpatient monitored group with unilateral epileptiform discharges and better than their monitored group with other interictal patterns. At the time of their monitoring, 1 week of inpatient monitoring was six times the cost of the outpatient EEGs and thus represented a significant cost saving. Unofficial estimates of the overall cost of the pre-surgical evaluation, without invasive monitoring, range from three to 10 times the cost of all three interictal tests at our institution. This could represent a substantial cost saving in those ineligible patients. However, a complete cost-effective study remains to be performed. Although the cost for each test may vary per institution and region, the order of increasing cost is relatively uniform; EEG < MRI < PET. Since costs are relatively specific per institution, similar relative cost ratios could be determined for each center to better assess their relative cost-effectiveness.
Occasionally, the cost of the comprehensive presurgical evaluation is more concerning to the patient than the surgery, especially if the outcome of the evaluation should result in surgical ineligibility. By performing these tests prior to the inpatient evaluation, the clinician would have a more definitive and costeffective assessment of their surgical eligibility. If the interictal tests were all negative, the clinician may consider other treatment options prior to considering the expensive inpatient pre-surgical evaluation.
